Children's Hospital of Wisconsin Investigational Drug Service — Milwaukee, Wisconsin

Children's Hospital of Wisconsin Investigational Drug Service is a clinical research site located in Milwaukee, Wisconsin, United States 53226.

Crixeo Clinical Trials Trust Score: 87/100 (GOOD). This profile has not yet been claimed by the site owner.

Children's Hospital of Wisconsin Investigational Drug Service has participated in 2 clinical trials.

Therapeutic areas: Dermatitis, Atopic, Atopic Dermatitis.

Sponsors: Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Milwaukee

Browse all research sites in Wisconsin · View every site in Milwaukee

Sponsor Feasibility Report

Trust Score: 87/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Children's Hospital of Wisconsin Investigational Drug Service?

Children's Hospital of Wisconsin Investigational Drug Service has a Crixeo Trust Score of 87/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Children's Hospital of Wisconsin Investigational Drug Service conducted?

Children's Hospital of Wisconsin Investigational Drug Service has 2 clinical trials on record. Their work covers Dermatitis, Atopic, Atopic Dermatitis.

Is Children's Hospital of Wisconsin Investigational Drug Service accredited by Crixeo Clinical Trials?

Children's Hospital of Wisconsin Investigational Drug Service has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Children's Hospital of Wisconsin Investigational Drug Service?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.